Brief: vTv Therapeutics Inc Says Nasdaq Notified Co That It Had Regained Compliance With Nasdaq Listing Rule On March 25
26/03/2024 21:06
March 26 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS INC - ON MARCH 25 NASDAQ NOTIFIED CO THAT
IT
HAD REGAINED COMPLIANCE WITH NASDAQ LISTING RULE
Source text for Eikon: ID:n0001641489-24-000020
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)